Literature DB >> 9060049

A retrospective study of clinical characteristics of acinetobacter bacteremia.

T K Ng1, J M Ling, A F Cheng, S R Norrby.   

Abstract

High rates of acinetobacter bacteremia were observed in a large teaching hospital in Hong Kong. A retrospective study of 94 acinetobacter bacteremic episodes in patients in 1993-94 revealed 70 episodes of significant bacteremia. 53% of the patients were over 60 years with a male to female ratio of 1.5:1. Cases were most rare during the fourth quarter. The intensive care unit was the commonest location of acquisition of bacteremia. Most infections were hospital acquired. Intravascular catheters, urinary catheters, antibiotic therapy and respiratory tract manipulations were common risk factors. Lower respiratory tract infections and catheter-related sepsis were predominant foci of bacteremia. One-third of the patients received appropriate antibiotics within 48 hours after bacteremia onset. Mortality attributable to acinetobacter infection was 27%. Prognosis of underlying diseases, location in intensive care unit, lower respiratory tract infection as foci of infection as well as diabetes mellitus were associated with mortality.

Entities:  

Mesh:

Year:  1996        PMID: 9060049

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  11 in total

1.  Skin carriage of acinetobacters in Hong Kong.

Authors:  Y W Chu; C M Leung; E T Houang; K C Ng; C B Leung; H Y Leung; A F Cheng
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Community-acquired Acinetobacter baumannii bacteremia in adult patients in Taiwan.

Authors:  Jann-Tay Wang; Lawrence Clifford McDonald; Shan-Chwen Chang; Monto Ho
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

3.  Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3.

Authors:  Sze-Lok Chau; Yiu-Wai Chu; Elizabeth T S Houang
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

4.  Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong.

Authors:  E T Houang; Y W Chu; C M Leung; K Y Chu; J Berlau; K C Ng; A F Cheng
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  First identification and characterization of an AdeABC-like efflux pump in Acinetobacter genomospecies 13TU.

Authors:  Ignasi Roca; Paula Espinal; Sara Martí; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

6.  Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study.

Authors:  Stijn Blot; Koenraad Vandewoude; Francis Colardyn
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

7.  Outbreak of nosocomial Acinetobacter baumannii bacteremia in a high risk ward.

Authors:  A Kapil; S Gulati; V Goel; L Kumar; R Krishnan; V Kochupillai
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

8.  Streptozocin-induced diabetic mouse model of urinary tract infection.

Authors:  David A Rosen; Chia-Suei Hung; Kimberly A Kline; Scott J Hultgren
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

9.  Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-beta-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000.

Authors:  Elizabeth T S Houang; Yiu-Wai Chu; Wai-Sing Lo; Ka-Yi Chu; Augustine F B Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.

Authors:  Song Yee Kim; Ji Ye Jung; Young Ae Kang; Joo Eun Lim; Eun Young Kim; Sang Kook Lee; Seon Cheol Park; Kyung Soo Chung; Byung Hoon Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Moo Suk Park
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.